Published in Ophthalmology on April 01, 1981
Central nervous system involvement in gyrate atrophy of the choroid and retina with hyperornithinaemia. J Inherit Metab Dis (1999) 0.80
Gyrate atrophy of the choroid and retina: ERG of the neural retina and the pigment epithelium. Br J Ophthalmol (1990) 0.77
Gyrate atrophy of the choroid and retina with hyperornithinemia, cystinuria and lysinuria responsive to vitamin B6. BMJ Case Rep (2011) 0.75
Myopathy with tubular aggregates and gyrate atrophy of the choroid and retina due to hyperornithinaemia. J Neurol Neurosurg Psychiatry (2006) 0.75
Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc Natl Acad Sci U S A (1981) 9.27
A quantitative in vitro focus assay for bovine papilloma virus. Virology (1980) 7.14
In vitro tumorigenic transformation by a defined sub-genomic fragment of bovine papilloma virus DNA. Nature (1980) 6.67
The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female. Neurology (1969) 2.94
Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci U S A (1991) 2.91
Inclusion body myositis and myopathies. Ann Neurol (1995) 2.68
Raised plasma-ornithine and gyrate atrophy of the choroid and retina. Lancet (1973) 2.56
Evidence for high-energy extraterrestrial neutrinos at the IceCube detector. Science (2013) 2.56
T cell lines mediating experimental autoimmune uveoretinitis (EAU) in the rat. J Immunol (1986) 2.55
Genetic defects and clinical characteristics of patients with a form of oculocutaneous albinism (Hermansky-Pudlak syndrome). N Engl J Med (1998) 2.42
Selective and nonselective susceptibility of muscle fiber types. A new approach to human neuromuscular diseases. Arch Neurol (1970) 2.33
NIH conference. Neurofibromatosis 1 (Recklinghausen disease) and neurofibromatosis 2 (bilateral acoustic neurofibromatosis). An update. Ann Intern Med (1990) 2.31
Cogan syndrome: studies in thirteen patients, long-term follow-up, and a review of the literature. Medicine (Baltimore) (1980) 2.26
Overexpression of connective tissue growth factor in podocytes worsens diabetic nephropathy in mice. Kidney Int (2007) 2.21
Central serous chorioretinopathy in endogenous hypercortisolism. Arch Ophthalmol (1993) 2.20
Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. I. Clinical and endocrinologic aspects. Neurology (1977) 2.19
Benefit from alternate-day prednisone in myasthenia gravis. N Engl J Med (1972) 2.00
First observation of PeV-energy neutrinos with IceCube. Phys Rev Lett (2013) 2.00
Muscle-specific mutations accumulate with aging in critical human mtDNA control sites for replication. Proc Natl Acad Sci U S A (2001) 1.94
The histographic analysis of human muscle biopsies with regard to fiber types. 4. Children's biopsies. Neurology (1969) 1.93
Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med (1972) 1.90
Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone. Lancet (1983) 1.90
Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet (1975) 1.84
Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet (1994) 1.84
Differentiation and oncogenesis: phenotypically distinct lens tumors in transgenic mice. New Biol (1989) 1.82
Difference in expression of phosphorylated tau epitopes between sporadic inclusion-body myositis and hereditary inclusion-body myopathies. J Neuropathol Exp Neurol (1996) 1.82
Ocular motor abnormalities in hereditary cerebellar ataxia. Brain (1976) 1.79
Single cholinergic receptor channel currents in cultured human muscle. J Neurosci (1982) 1.79
Subdural tension pneumocephalus following surgery for chronic subdural hematoma. J Neurosurg (1988) 1.75
Cooperativity in oxidations catalyzed by cytochrome P450 3A4. Biochemistry (1997) 1.72
Oculocraniosomatic neuromuscular disease with "ragged-red" fibers. Arch Neurol (1972) 1.72
Gyrate atrophy of the choroid and retina associated with hyperornithinaemia. Br J Ophthalmol (1974) 1.70
Neuromuscular disease in primary hyperparathyroidism. Ann Intern Med (1974) 1.69
The histographic analysis of human muscle biopsies with regard to fiber types. 2. Diseases of the upper and lower motor neuron. Neurology (1969) 1.64
Classic nephropathic cystinosis as an adult disease. JAMA (1993) 1.62
The kin-cohort study for estimating penetrance. Am J Epidemiol (1998) 1.60
Autosomal dominant congenital cataract. Interocular phenotypic variability. Ophthalmology (1994) 1.60
Immunohistologic findings and results of treatment with cyclosporine in ligneous conjunctivitis. Am J Ophthalmol (1989) 1.57
Corneal crystals in nephropathic cystinosis: natural history and treatment with cysteamine eyedrops. Mol Genet Metab (2000) 1.56
Gyrate atrophy of the choroid and retina: deficiency of ornithine aminotransferase in transformed lymphocytes. Proc Natl Acad Sci U S A (1977) 1.56
Genetic aspects in gyrate atrophy of the choroid and retina with hyperornithinaemia. Br J Ophthalmol (1974) 1.54
Germ-line mutations in the neurofibromatosis 2 gene: correlations with disease severity and retinal abnormalities. Am J Hum Genet (1996) 1.52
Use of anti-neurofilament antibody to identify paired-helical filaments in inclusion-body myositis. Ann Neurol (1996) 1.51
Purification and characterization of 33 kilodalton protein of spinach chloroplasts. Biochim Biophys Acta (1979) 1.51
Axoplasmic flow during chronic experimental glaucoma. 1. Light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping. Invest Ophthalmol Vis Sci (1978) 1.51
The histopathology of pigmentary dispersion syndrome with glaucoma. Am J Ophthalmol (1975) 1.50
Evoked potential analysis of visual pathways in human albinism. Ophthalmology (1994) 1.50
beta-Amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol (1993) 1.49
Chronic relapsing (dysimmune) polyneuropathy: pathogenesis and treatment. Ann Neurol (1981) 1.48
Myoglobinaemia in Duchenne muscular dystrophy patients and carriers: A new adjunct to carrier detection. Lancet (1978) 1.48
Histochemical studies of denervated or tenotomized cat muscle: illustrating difficulties in relating experimental animal conditions to human neuromuscular diseases. Ann N Y Acad Sci (1966) 1.48
Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features. Invest Ophthalmol Vis Sci (1985) 1.47
Type I fiber hypotrophy and central nuclei. A rare congenital muscle abnormality with a possible experimental model. Arch Neurol (1968) 1.47
Light and electron microscopic localization of beta-amyloid protein in muscle biopsies of patients with inclusion-body myositis. Am J Pathol (1992) 1.47
Interferon induces morphologic reversion with elimination of extrachromosomal viral genomes in bovine papillomavirus-transformed mouse cells. Proc Natl Acad Sci U S A (1982) 1.46
"Type grouping" in skeletal muscles after experimental reinnervation. Neurology (1968) 1.46
Tubular aggregates in type II muscle fibers: ultrastructural and histochemical correlation. J Ultrastruct Res (1970) 1.42
Acetazolamide treatment of hypokalemic periodic paralysis. Prevention of attacks and improvement of persistent weakness. Ann Intern Med (1970) 1.41
Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms. J Clin Oncol (2001) 1.41
Paralysis of innervated cultured human muscle fibers affects enzymes differentially. J Neurochem (1990) 1.40
The mural cell in perspective. Arch Ophthalmol (1967) 1.39
S-antigen uveitis in primates. A new model for human disease. Arch Ophthalmol (1981) 1.39
Retinal changes produced by phototherapy. J Pediatr (1970) 1.38
Twisted tubulofilaments of inclusion body myositis muscle resemble paired helical filaments of Alzheimer brain and contain hyperphosphorylated tau. Am J Pathol (1994) 1.37
Axonal transport of proteins in experimental neuropathies. Science (1969) 1.36
The maturation of the lens cell: a morphologic study. Exp Eye Res (1975) 1.35
Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy. Arch Ophthalmol (1966) 1.35
Transfer of beta-amyloid precursor protein gene using adenovirus vector causes mitochondrial abnormalities in cultured normal human muscle. Proc Natl Acad Sci U S A (1996) 1.33
A new program for investigating adult human skeletal muscle grown aneurally in tissue culture. Neurology (1975) 1.31
A 5-base insertion in the gammaC-crystallin gene is associated with autosomal dominant variable zonular pulverulent cataract. Hum Genet (2000) 1.31
Polymyositis: remarkable response to total body irradiation. Lancet (1981) 1.30
The histographic analysis of human muscle biopsies with regard to fiber types. 3. Myotonias, myasthenia gravis, and hypokalemic periodic paralysis. Neurology (1969) 1.29
Retinal damage by visible light. An electron microscopic study. Arch Ophthalmol (1968) 1.29
Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein. Cancer Res (1998) 1.28
Hermansky-Pudlak syndrome type 3 in Ashkenazi Jews and other non-Puerto Rican patients with hypopigmentation and platelet storage-pool deficiency. Am J Hum Genet (2001) 1.28
Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest Ophthalmol Vis Sci (1986) 1.27
The essentiality of histo- and cytochemical studies of skeletal muscle in the investigation of neuromuscular disease. 1962. Neurology (1998) 1.27
New hypothesis of developmental anomalies of the anterior chamber associated with glaucoma. Trans Ophthalmol Soc U K (1978) 1.26
Experimental myopathy after microarterial embolization; comparison with childhood x-linked pseudohypertrophic muscular dystrophy. Arch Neurol (1970) 1.26
Duchenne muscular dystrophy: functional ischemia reproduces its characteristic lesions. Science (1971) 1.26
Thrombotic occlusion of the middle cerebral artery. Stroke (1992) 1.25
Histochemical investigation of fiber type ratios with the myofibrillar ATP-ase reaction in normal and denervated skeletal muscles of guinea pig. Am J Anat (1968) 1.22
Purification of retinal S-antigen to homogeneity by the criterion of gel electrophoresis silver staining. Invest Ophthalmol Vis Sci (1984) 1.22
Inclusion-body myositis: newest concepts of pathogenesis and relation to aging and Alzheimer disease. J Neuropathol Exp Neurol (2001) 1.22
Eye findings in bilateral acoustic (central) neurofibromatosis: association with presenile lens opacities and cataracts but absence of Lisch nodules. N Engl J Med (1986) 1.21
Tamoxifen retinopathy. Cancer Treat Rep (1978) 1.21
Impaired skeletal muscle maturation following neonatal neurectomy. Dev Biol (1968) 1.21
X-linked inheritance of epidermodysplasia verruciformis. Genetic and virologic studies of a kindred. Arch Dermatol (1985) 1.21
Microcystic dystrophy of the cornea. A partial explanation for its pathogenesis. Arch Ophthalmol (1974) 1.20
Neuronal trophic function. A new aspect demonstrated histochemically in developing soleus muscle. Arch Neurol (1967) 1.20
Electron microscopy of posterior polymorphous degeneration. Am J Ophthalmol (1971) 1.20
Correlative histochemical study of skeletal muscle after suprasegmental denervation, peripheral nerve section, and skeletal fixation. Neurology (1968) 1.20
Subacute sclerosing panencephalitis. Spontaneous improvement in a patient with elevated measles antibody in blood and spinal fluid. N Engl J Med (1968) 1.19
Frameshift and novel mutations in FUS in familial amyotrophic lateral sclerosis and ALS/dementia. Neurology (2010) 1.19
beta-Amyloid precursor protein mRNA is increased in inclusion-body myositis muscle. Neuroreport (1993) 1.19